Diagnostic value of serum soluble suppression of tumorigenicity 2 in patients with heart failure in different types of heart diseases
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 4
Abstract
Objective To observe the changes of soluble growth stimulation expression gene 2 (sST2) level in patients with heart failure in different types of heart diseases, and analyze the diagnostic value of sST2 in heart failure. Methods A total of 74 patients with heart failure admitted to the Department of Rehabilitation, Hefei Cancer Hospital, Chinese Academy of Sciences, from January 2021 to May 2022 were selected, including 24 patients with coronary artery disease (CAD group), 25 patients with atrial fibrillation (AF group) and 25 patients with hypertensive heart disease (HHD group). Additional 26 healthy individuals during the same period were selected as the control group. Serum sST2 levels were measured and compared between the observation groups and the control group. The differences in serum sST2 levels in patients with different severities of heart failure were analyzed, and the diagnostic efficacy of sST2 and N-terminal pro B-type natriuretic peptide (NT-proBNP) was compared. Results The serum sST2 levels in the CAD group, AF group, and HHD group were (50.02±19.43) ng/mL, (57.26±19.07) ng/mL, and (44.79±16.50) ng/mL, respectively, which were significantly higher than that in the control group ［(20.55±4.33) ng/mL, P＜0.01］. As the heart failure grade increased, the serum sST2 levels also increased, with statistical significance (F=15.097, P＜0.01). The specificity of serum sST2 combined with NT-proBNP in diagnosing heart failure of different severities was 83.33%, the sensitivity was 92.00%, and the area under the curve (AUC) was 0.95. Conclusion The level of serum sST2 is an important indicator of heart failure caused by different types of heart disease, and combined with NT-proBNP is effective in the diagnosis of this disease.
Authors and Affiliations
XIA Li*, YIN Yi, ZHOU Dewei, WU Jiaming, WANG Hongzhi *Department of Internal Medicine, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui 230000, China
Keywords
Related Articles
- EP ID EP764832
- DOI 10.13429/j.cnki.cjcr.2025.04.017
- Views 22
- Downloads 0
Effect of different administration methods of esketamine on postoperative pain after thoracoscopic lung surgery
Objective To investigate the effect of itravenous injection or infuson of esketamine on postoperative pain in patients undergoing thoracoscopic lung surgery. Methods A total of 90 patients who underwent elective thorac...
Research progress of DEAD-box polypeptide 5 in breast cancer
Breast cancer, as a malignant tumor threatening the survival of women in China, its incidence rate is increasing year by year and showing a younger trend, control of cancer cell proliferation, invasion, metastasis is the...
Ultrasound artificial intelligence in the assessment of liver fibrosis
Liver fibrosis is a necessary step in the progression of various chronic liver diseases to cirrhosis and hepatocellular carcinoma, so early diagnosis of liver fibrosis is of great clinical significance. Ultrasound is the...
Symptom clusters in patients with hypertensive cerebral haemorrhage during the acute phase and their correlation with prognostic quality of life
<b>Objective</b> To explore the composition of symptom clusters in the acute phase of patients with hypertensive cerebral haemorrhage and to analyse their correlation with prognostic quality of life. <b>Methods</b> From...
Application of shared care management model in type 2 diabetes
Objective To assess the impact of the shared care management model on control levels of blood glucose, blood lipid and blood pressure in patients with type 2 diabetes mellitus (T2DM). Methods From July 2020 to February...